Branched polyamines cure prion-infected neuroblastoma cells
about
Continuous quinacrine treatment results in the formation of drug-resistant prionsEvaluation of quinacrine treatment for prion diseasesAnti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc)Discovery of a novel, monocationic, small-molecule inhibitor of scrapie prion accumulation in cultured sheep microglia and Rov cellsTetracyclines affect prion infectivity.Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.Chemical induction of misfolded prion protein conformers in cell culture.Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.Mouse models for studying the formation and propagation of prions.Prions in skeletal muscle.Inactivation of prions by acidic sodium dodecyl sulfateInterventional strategies against prion diseases.Prions.Prion protein-specific antibodies-development, modes of action and therapeutics applicationAntiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.The transmissible spongiform encephalopathies: pathogenic mechanisms and strategies for therapeutic intervention.A survey of antiprion compounds reveals the prevalence of non-PrP molecular targets.Phosphorothioate oligonucleotides reduce PrP levels and prion infectivity in cultured cells.Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.Antiprion immunotherapy: to suppress or to stimulate?Recent advances in prion chemotherapeutics.A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in RodentsPharmacokinetics and metabolism of 2-aminothiazoles with antiprion activity in mice.Therapeutic approaches for prion disorders.Prions: Beyond a Single Protein.Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes.Complex polyamines: unique prion disaggregating compounds.Dendrimers as therapeutic agents: a systematic review.Nanomaterials for reducing amyloid cytotoxicity.Prion degradation pathways: Potential for therapeutic intervention.Generation of Infectious Prions and Detection with the Prion-Infected Cell Assay.Effect of poly-L-arginine in inhibiting scrapie prion protein of cultured cells.Bioassays and Inactivation of Prions.In silico strategies on prion pathogenic conversion and inhibition from PrPC -PrPSc.Preference toward a polylysine enantiomer in inhibiting prions.Polypropylenimine generation four: a suitable vector for targeted gene alteration in vitro.Implications of peptide assemblies in amyloid diseases.The suppression of prion propagation using poly-L-lysine by targeting plasminogen that stimulates prion protein conversion.
P2860
Q21090510-D5121E72-DC0B-4379-9517-A1564C1065DAQ24682427-8E2E1EB4-74E5-4D5F-B47D-2226929DB9FEQ28485325-463DAA35-A8D5-47AE-8E88-9A878E38FA55Q28485431-990C7BD7-CD7E-4677-9BEF-8198DE487C7FQ30531528-423CD8EF-E7DB-4F05-AFAF-38FBF48696ECQ31134598-1F022C76-0550-47A9-887F-60CC2CF70903Q31156724-2E4BF851-3B62-43FB-AB48-C98D6FE8DF89Q33740696-C2B483F2-B1E1-47FC-B158-A02F68E1CEB7Q33796040-63BC213A-7D4D-402E-A1FC-775511DC293AQ33930771-3E1BB305-4D57-420C-AE79-D08C48808656Q33931079-2EA9979A-293A-4B70-B4BB-C860AC37F85CQ34020521-9EA362C2-64B6-4C2E-89D3-B02883B7A466Q34232938-F073FCB8-4F4B-408E-8EF4-98E3E8EB937CQ34389564-08848BA1-AC47-4156-8A5C-8B19E7102A17Q34413061-FB75ED11-A0FB-459D-B208-68E600707A22Q34423386-7C3C983D-4F2D-4FF3-81F5-789EAB749858Q35030768-E2FAA5BC-7740-4FF8-B622-3552EBAC32F3Q35050425-FA63F0C1-2F1B-4569-A99C-52CB3E88A079Q35145020-D9A84EB1-FD15-427B-8256-B28F0FBB6670Q35844090-012337C8-15ED-4056-9F68-A52231F21FD7Q35865508-6A500B40-691E-4962-86D6-8655DBC59636Q35877214-4C5D58B5-0D0E-4BFD-9FFD-ED1A625A0A31Q35944199-DA385401-480B-4D88-A3B3-006AC1ECB7B5Q36223572-7C4607B8-CBE4-4A8B-A54E-E6DA9BA3F437Q36806526-1C7AC8F4-CF5F-4EA5-94BC-ABB324F61467Q36901944-C17903B3-8751-4A7B-B51A-9A2239012704Q37162363-0C7A465C-9E8B-46E7-BABE-1D46442B5D22Q37415409-B913E64A-59DC-4207-BD1D-F65FC69391B6Q37585423-FCB9D3E8-B335-47BB-BD8A-DACC9E720CA7Q37585659-C7FBC1C4-831F-444B-85B7-E4A46F95D6DFQ38110699-D01A0632-0CFD-421D-8C77-E7A8233E1256Q38316783-EE25ED7B-8FF6-4E6A-B8B8-D9D2FE9D74DCQ38693596-E3119B8B-F03D-46EE-9B62-0CA0FE7F3D73Q38722543-4423DEF1-F51A-495D-9004-321C8CD91A6EQ38936788-DFE07AFF-C65B-4FD7-8817-59A8A90DD4D6Q39101358-9832AAB6-28CA-44FE-8ADF-95E8411687D3Q39239262-06DC3C13-3A7C-4F23-AD6F-84115D745DDCQ39350059-DA8BD39C-B6D6-49EF-9965-FB4B36BC95EBQ39431937-FCD27A18-AC89-423C-B8DB-6D5A0CDAF35CQ39599032-6280A483-EBDC-46AC-B636-988D665A5BC9
P2860
Branched polyamines cure prion-infected neuroblastoma cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Branched polyamines cure prion-infected neuroblastoma cells
@ast
Branched polyamines cure prion-infected neuroblastoma cells
@en
Branched polyamines cure prion-infected neuroblastoma cells
@en-gb
Branched polyamines cure prion-infected neuroblastoma cells
@nl
type
label
Branched polyamines cure prion-infected neuroblastoma cells
@ast
Branched polyamines cure prion-infected neuroblastoma cells
@en
Branched polyamines cure prion-infected neuroblastoma cells
@en-gb
Branched polyamines cure prion-infected neuroblastoma cells
@nl
prefLabel
Branched polyamines cure prion-infected neuroblastoma cells
@ast
Branched polyamines cure prion-infected neuroblastoma cells
@en
Branched polyamines cure prion-infected neuroblastoma cells
@en-gb
Branched polyamines cure prion-infected neuroblastoma cells
@nl
P2093
P2860
P1433
P1476
Branched polyamines cure prion-infected neuroblastoma cells
@en
P2093
P Tremblay
S Supattapone
P2860
P304
P356
10.1128/JVI.75.7.3453-3461.2001
P407
P577
2001-04-01T00:00:00Z